Literature DB >> 9628456

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.

S A Kolb1, F Lahrtz, R Paul, D Leppert, D Nadal, H W Pfister, A Fontana.   

Abstract

A hallmark of viral meningitis is the invasion of monocytes, lymphocytes and, in the initial phase of the disease, neutrophils into the subarachnoidal space. By their degradation of different macromolecular components in the extracellular connective tissue, matrix metalloproteinases (MMPs) may be essential for the breakdown of the vessel wall in the meninges and the choroid plexus. In this study, the occurrence of MMP-1, MMP-2, MMP-3 and MMP-9 and the two tissue inhibitors of metalloproteinases, TIMP-1 and TIMP-2, was monitored in the cerebrospinal fluid (CSF) from patients with viral meningitis. Of the proteinases, MMP-9 was found in 13 of 39 (33%) patients, but not in controls; the levels being correlated with the neutrophil cell number in CSF. The CSF concentration of TIMP-1 was increased three-fold compared to the control group (median 233 ng/ml; range 9.4-1252.5 ng/ml) and was correlated to the levels of total protein in CSF. Of the other MMPs and TIMPs assayed, MMP-2 and TIMP-2 were constitutively expressed and not upregulated in viral meningitis. High levels of MMP-9 and MMP-2, as measured by ELISA, was associated with high proteolytic activity detected in CSF by zymography. In conclusion, invasion of the leukocytes into the CSF compartment in viral meningitis may involve MMP-9, its proteolytic effect likely being controlled by expression of TIMP-1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9628456     DOI: 10.1016/s0165-5728(97)00247-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  27 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.

Authors:  S L Leib; D Leppert; J Clements; M G Täuber
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 3.  The paradox of matrix metalloproteinases in infectious disease.

Authors:  P T G Elkington; C M O'Kane; J S Friedland
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis.

Authors:  Ke-Min Chen; Jer-Yuh Liu; Shih-Chan Lai; Li-Sung Hsu; Hsiu-Hsiung Lee
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

Review 5.  Chemotactic factors in cerebrospinal fluid during bacterial meningitis.

Authors:  Petra J G Zwijnenburg; Tom van der Poll; John J Roord; A Marceline van Furth
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

6.  Upregulation of MMP-9/TIMP-1 enzymatic system in eosinophilic meningitis caused by Angiostrongylus cantonensis.

Authors:  Ke-Min Chen; Hsiu-Hsiung Lee; Hui-Lin Chou; Jer-Yuh Liu; Bo-Cyuan Tsai; Shih-Chan Lai
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

Review 7.  Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis.

Authors:  Hui Liu; Ke Qiu; Qiang He; Qiang Lei; Wei Lu
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-19       Impact factor: 4.147

8.  Association of matrix metalloproteinase-9 in eosinophilic meningitis of BALB/c mice caused by Angiostrongylus cantonensis.

Authors:  H H Lee; H L Chou; K M Chen; S C Lai
Journal:  Parasitol Res       Date:  2004-09-21       Impact factor: 2.289

9.  Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8.

Authors:  Alexandra Schubert-Unkmeir; Christian Konrad; Heiko Slanina; Florian Czapek; Sabrina Hebling; Matthias Frosch
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

10.  Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.

Authors:  Xiaomeng Ma; Ying Jiang; Aimin Wu; Xiaohong Chen; Rongbiao Pi; Mei Liu; Yingying Liu
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.